[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"brain-stroke\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:brain-stroke":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100620335","phase-3-emergent-large-vessel-occlusion-endovascular-rescue-therapy-with-underlying-intracranial-stenosis-100620335",false,"NCT07356284","Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis","EVEREST","Inclusion Criteria:\n\n1. 18 to 80 years of age\n2. Presenting with symptoms consistent with AIS\n3. Imaging evidence of an anterior occlusion of the Internal Carotid Artery (ICA) or Middle Cerebral Artery Main Stem (MCA M1), or proximal M2 segment AND residual 70-99% stenosis of the index artery following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling\n4. NIHSS ≥ 6\n5. Ability to randomize within 24 hours of stroke onset.\n6. Pre-stroke mRS score 0-2\n7. Ability to obtain signed informed consent.\n8. ASPECTS Score ≥ 6 by non-contrast CT scan\n9. Score-ICAD score of ≥11 points at screening and\u002For persistent stenotic occlusion of ≥70% after MT\n10. If indicated, thrombolytic therapy shall be initiated per the institution's usual care and the most recent version of the AHA\u002FASA Guidelines. Subjects eligible for IV thrombolysis should receive it without delay.\n11. For subjects presenting \\>6 hours from stroke onset, infarct core volume \\\u003C50 cc quantified by CTP\n\nExclusion Criteria:\n\n1. Females who are pregnant, or those of child-bearing potential with positive urine or serum beta Human Chorionic Gonadotropin (HCG) test\n2. Known severe allergy (more than a rash) to contrast media uncontrolled by medications.\n3. CT evidence of the following conditions:\n\n   * Midline shift or herniation\n   * Evidence of intracranial hemorrhage\n   * Mass effect with effacement of the ventricles\n4. Acute bilateral strokes\n5. Contraindication to antiplatelet (aspirin, clopidogrel, ticagrelor, cangrelor) or contrast agents\n6. Intracranial tumors other than small meningioma, that do not require surgery for at least one year post randomization. Small meningioma is defined as a lesion measuring ≤20mm in maximum diameter or ≤4cm3 in volume, with no associated mass effect, peritumoral edema, or progressive neurological symptoms\n7. Known hemorrhagic diathesis, coagulation factor deficiency, or on anticoagulant therapy with an International Normalized Ratio (INR) of \\>3.0 or Partial Thromboplastin Time (PTT) \\>3 times of normal\n8. Baseline platelet count \\\u003C80,000 per microliter (µl)\n9. Life expectancy less than one year prior to stroke onset\n10. Participation in another randomized clinical trial that could confound the evaluation of the study outcomes.\n11. Any other condition (in the opinion of the site investigator) that precludes an endovascular procedure or poses a significant hazard to the patient if an endovascular procedure was performed\n12. New diagnosis of atrial fibrillation or a history of atrial fibrillation\n13. Suspected device-induced vasospasm defined as smooth transient narrowing of the target vessel\n14. Vessel dissection including any of the following: presence of dissection flap, false lumen, contrast stagnation in the vessel wall, and\u002For improving stenosis\n\n    \\-","ALL","18 Years","80 Years",{"count":20,"type":21},342,"ESTIMATED","INTERVENTIONAL",[24],"PHASE3","The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.",[27,28,29],"Brain Stroke","Stenting Treatment","Acute Ischemic Stroke",[31,32],"mechanical thrombectomy","Acute Ischemic stroke","RECRUITING","2026-05-20",{"date":36,"type":37},"2026-05-22","ACTUAL",{"date":39,"type":37},"2026-05-19",{"date":41,"type":21},"2030-06-01",{"name":43,"class":44},"ProMedica Health System","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":56,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":62,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":45},"100597346","residual-stenosis-and-restenosis-following-carotid-endarterectomy-with-primary-closure-a-prospective-tracking-study-100597346","NCT07057297","Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study","RECEPT","Inclusion Criteria:\n\nPatients without matching any of exclusion criteria who underwent cartotid endarterectomy\n\nExclusion Criteria:\n\nAge ≤18 or ≥90 years\n\nPrevious endarterectomy or stenting\n\nUnsuitable vascular anatomy\n\nHigh perioperative risk\n\nContralateral cranial nerve X or XII palsy\n\nHistory of neck irradiation\n\nTandem carotid stenosis or intracranial vascular pathology (e.g., aneurysm or AVM)\n\nAbsence of signed informed consent","90 Years",{"count":55,"type":21},300,"1 Year","OBSERVATIONAL","This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications.\n\nParticipants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.",[60,61,27],"Carotid Arteriosclerosis","Carotid Stenosis",[63,64,65,66],"Carotid Artery","Atherosclerosis","Endarterectomy","Stroke","2025-06-30",{"date":69,"type":37},"2025-07-09",{"date":71,"type":37},"2025-02-01",{"date":73,"type":21},"2027-01-01",{"name":75,"class":44},"Charles University, Czech Republic"]